Modified periodontal risk assessment score: long-term predictive value of treatment outcomes. A retrospective study

J Clin Periodontol. 2010 May;37(5):427-35. doi: 10.1111/j.1600-051X.2010.01553.x.

Abstract

Objective: The aim of this study was to evaluate the long-term clinical predictive value of the periodontal risk assessment diagram surface (PRAS) score and the influence of patient compliance on the treatment outcomes.

Materials and methods: Thirty subjects suffering from periodontitis were re-examined 6-12 years after the initial diagnosis and periodontal treatments. The baseline PRAS score was calculated from the initial clinical and radiograph records. Patients were then classified into a low-to-moderate (0-20) or a high-risk group (>20). Patients who did not attend any supportive periodontal therapy were classified into a non-compliant group. PRAS and compliance were correlated to the mean tooth loss (TL)/year and the mean variation in the number of periodontal pockets with a probing depth (PPD) >4 mm.

Results: TL was 0.11 for the low-to-moderate-risk group and 0.26 for the high-risk group (p<0.05); PPD number reduction was 2.57 and 2.17, respectively, and bleeding on probing reduction was 6.7% and 23.3%, respectively. Comparing the compliance groups, the PPD number reduction was 3.39 in the compliant group and 1.40 in the non-compliant group (p<0.05).

Conclusion: This study showed the reliability of PRAS in evaluating long-term TL and patient susceptibility to periodontal disease. Our data confirmed the positive influence of patient compliance on periodontal treatment outcomes.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aggressive Periodontitis / complications
  • Aggressive Periodontitis / immunology
  • Aggressive Periodontitis / therapy*
  • Anti-Infective Agents, Local / therapeutic use
  • Chronic Periodontitis / complications
  • Chronic Periodontitis / immunology
  • Chronic Periodontitis / therapy*
  • Dental Scaling
  • Disease Susceptibility
  • Female
  • Humans
  • Linear Models
  • Longitudinal Studies
  • Male
  • Metronidazole / therapeutic use
  • Middle Aged
  • Patient Compliance
  • Periodontal Index
  • Prognosis
  • Retrospective Studies
  • Risk Assessment / methods
  • Spiramycin / therapeutic use
  • Tooth Loss / etiology
  • Treatment Outcome

Substances

  • Anti-Infective Agents, Local
  • Metronidazole
  • Spiramycin